Allergan pushes to kick Valeant, Pershing out of special shareholder meeting

Allergan is still looking to prevent Valeant Pharmaceuticals and Pershing Square from voting their shares in a December 18 shareholder meeting the company was forced to host.

Pershing Square Capital Management, Valeant Pharmaceuticals, Allergan Inc.

Legal News, News Well, Mergers & Acquisitions, Pharmaceuticals, Wall Street Beat

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1qcSuv4